Okada K, Kagami S
Department of Pediatrics, School of Medicine, Tokushima University.
Jpn J Antibiot. 1990 May;43(5):890-4.
Norfloxacin (NFLX, AM-715), a new synthetic antibacterial agent, was administered to 18 child patients with infectious diseases. The patients included 5 boys and 13 girls from 3 to 14 years of ages. They were given orally dosage ranging 5.2-17.9 mg/kg/day for 4 to 14 days. Clinical efficacies were excellent in 1 case, good in 16 cases, unknown in 1 case, hence the total efficacy rate was determined to be 100%. There were no cases which showed side effects of the drug and no abnormal laboratory test values were observed during the treatment.
诺氟沙星（NFLX，AM - 715），一种新型合成抗菌剂，被用于18名患有传染病的儿童患者。这些患者包括5名男孩和13名女孩，年龄在3至14岁之间。他们口服给药，剂量为5.2 - 17.9毫克/千克/天，持续4至14天。临床疗效为优1例，良16例，不明1例，因此总有效率确定为100%。没有出现该药物副作用的病例，治疗期间也未观察到异常的实验室检查值。
